Access Bio company has scheduled its next shareholders meeting...

Access Bio company has scheduled its next shareholders meeting for 25 Mar'21 (as Sth Korea FY runs Jan-Dec period)

Due to Sth Korea financial disclosure requirements - as the company has made than 30% of sales or profit and loss structure already - its had to release consolidated $ statement - before the shareholder's meeting....which is very interesting reading

9 Feb'21 - Consolidated statement
_{http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210209900437}

Copy of the finance table within - amts in US$



Almost all of this extra profit rev is from those rapid fire Access Bio Ag test sales orders (since Sept'20)...and this statement does not include the US$70m ordered in Jan'21...so they are well on their way already to potentially exceeding this total for FY21/CY21 period...